Grifols (GRFS) Enterprise Value Growth (3y) (2012 - 2025)

Grifols (GRFS) Enterprise Value Growth (3y) (2012 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	-16.86%
Dec 31, 2024	29.74%
Dec 31, 2023	-35.42%
Dec 31, 2022	-6.89%
Dec 31, 2021	-65.92%
Dec 31, 2020	46.92%
Dec 31, 2019	19.87%
Sep 30, 2019	404.42%
Dec 31, 2018	18.93%
Sep 30, 2018	-19.08%
Jun 30, 2018	935.93%
Mar 31, 2018	397.33%
Dec 31, 2017	7.87%
Jun 30, 2017	-8.28%
Dec 31, 2016	-0.13%
Sep 30, 2016	26.14%
Jun 30, 2016	26.15%
Dec 31, 2015	-27.00%
Sep 30, 2015	26.21%
Jun 30, 2015	25.99%